SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shilpa Medicare - Quaterly Results

08 Feb 2024 Evaluate
A fair growth of 23.89% in the revenue at Rs. 639.79 millions was reported in the December 2023 quarter as compared to Rs. 516.42 millions during year-ago period.The Total Profit for the quarter ended December 2023 of Rs. 26.98 millions grew from Rs.-47.87 millionsOperating profit surged to 190.29 millions from the corresponding previous quarter of 73.42 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 639.79 516.42 23.89 2223.34 1812.07 22.70 2477.02 3569.52 -30.61
Other Income 223.26 175.97 26.87 658.69 483.12 36.34 686.44 408.62 67.99
PBIDT 190.29 73.42 159.18 852.04 180.84 371.16 246.44 625.49 -60.60
Interest 26.08 66.41 -60.73 145.46 142.17 2.31 208.25 90.54 130.01
PBDT 163.03 7.01 2225.68 639.91 32.82 1849.76 -117.27 623.04 -118.82
Depreciation 123.94 122.57 1.12 373.24 345.69 7.97 465.48 348.18 33.69
PBT 39.09 -115.56 -133.83 266.67 -312.87 -185.23 -582.75 274.86 -312.02
TAX 12.11 -67.69 -117.89 94.64 -107.30 -188.20 -87.93 73.27 -220.01
Deferred Tax -0.83 -47.50 -98.25 3.62 -34.25 -110.57 -4.27 25.25 -116.91
PAT 26.98 -47.87 -156.36 172.03 -205.57 -183.68 -494.82 201.59 -345.46
Equity 86.80 86.80 0.00 86.80 86.80 0.00 86.80 86.80 0.00
PBIDTM(%) 29.74 14.22 109.20 38.32 9.98 284.00 9.95 17.52 -43.22

Shilpa Medicare Share Price

411.55 0.30 (0.07%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×